Amarantus Bioscience Holdings Stock Price Prediction
| AMBS Stock | USD 0.0001 0.00 0.00% |
Oversold Vs Overbought
45
Oversold | Overbought |
Using Amarantus Bioscience hype-based prediction, you can estimate the value of Amarantus Bioscience Holdings from the perspective of Amarantus Bioscience response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Amarantus Bioscience to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Amarantus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Amarantus Bioscience after-hype prediction price | USD 9.6E-5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Amarantus |
Amarantus Bioscience After-Hype Price Prediction Density Analysis
As far as predicting the price of Amarantus Bioscience at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Amarantus Bioscience or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Amarantus Bioscience, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Amarantus Bioscience Estimiated After-Hype Price Volatility
In the context of predicting Amarantus Bioscience's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Amarantus Bioscience's historical news coverage. Amarantus Bioscience's after-hype downside and upside margins for the prediction period are 0.00 and 50.01, respectively. We have considered Amarantus Bioscience's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Amarantus Bioscience is out of control at this time. Analysis and calculation of next after-hype price of Amarantus Bioscience is based on 3 months time horizon.
Amarantus Bioscience Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Amarantus Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Amarantus Bioscience backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Amarantus Bioscience, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
22.30 | 130.83 | 0.00 | 8.14 | 0 Events / Month | 5 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.0001 | 0.000096 | 4.29 |
|
Amarantus Bioscience Hype Timeline
Amarantus Bioscience is presently traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 8.14. Amarantus is forecasted to decline in value after the next headline, with the price expected to drop to 9.6E-5. The average volatility of media hype impact on the company price is insignificant. The price decrease on the next news is expected to be -4.29%, whereas the daily expected return is presently at 22.3%. The volatility of related hype on Amarantus Bioscience is about 35843.84%, with the expected price after the next announcement by competition of 8.14. The company recorded a loss per share of 0.03. Amarantus Bioscience had not issued any dividends in recent years. The entity had 1:150 split on the 10th of June 2015. Given the investment horizon of 90 days the next forecasted press release will be in 5 to 10 days. Check out Amarantus Bioscience Basic Forecasting Models to cross-verify your projections.Amarantus Bioscience Related Hype Analysis
Having access to credible news sources related to Amarantus Bioscience's direct competition is more important than ever and may enhance your ability to predict Amarantus Bioscience's future price movements. Getting to know how Amarantus Bioscience's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Amarantus Bioscience may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RZLT | Rezolute | (0.28) | 7 per month | 3.08 | 0.03 | 6.81 | (5.54) | 30.01 | |
| TPST | Tempest Therapeutics | (0.09) | 4 per month | 0.00 | (0.13) | 6.38 | (8.53) | 29.55 | |
| FBRX | Forte Biosciences | 3.09 | 5 per month | 3.41 | 0.11 | 6.65 | (6.33) | 126.20 | |
| DYAI | Dyadic International | (0.03) | 7 per month | 3.66 | 0.08 | 9.00 | (7.20) | 16.89 | |
| DMAC | DiaMedica Therapeutics | 0.19 | 6 per month | 2.11 | 0.04 | 4.94 | (3.29) | 10.25 | |
| SILO | Silo Pharma | 0.00 | 0 per month | 0.00 | (0.15) | 6.31 | (10.57) | 23.28 | |
| MOLN | Molecular Partners AG | (0.10) | 5 per month | 5.04 | (0.01) | 9.61 | (8.53) | 52.92 | |
| MLYS | Mineralys Therapeutics, Common | 0.14 | 8 per month | 3.42 | 0.02 | 6.27 | (5.79) | 20.98 |
Amarantus Bioscience Additional Predictive Modules
Most predictive techniques to examine Amarantus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Amarantus using various technical indicators. When you analyze Amarantus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Amarantus Bioscience Predictive Indicators
The successful prediction of Amarantus Bioscience stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Amarantus Bioscience Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Amarantus Bioscience based on analysis of Amarantus Bioscience hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Amarantus Bioscience's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Amarantus Bioscience's related companies.
Story Coverage note for Amarantus Bioscience
The number of cover stories for Amarantus Bioscience depends on current market conditions and Amarantus Bioscience's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Amarantus Bioscience is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Amarantus Bioscience's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Additional Tools for Amarantus Pink Sheet Analysis
When running Amarantus Bioscience's price analysis, check to measure Amarantus Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amarantus Bioscience is operating at the current time. Most of Amarantus Bioscience's value examination focuses on studying past and present price action to predict the probability of Amarantus Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amarantus Bioscience's price. Additionally, you may evaluate how the addition of Amarantus Bioscience to your portfolios can decrease your overall portfolio volatility.